TITLE

Validating a Simple Scoring System to Predict Malignancy and Invasiveness of Intraductal Papillary Mucinous Neoplasms of the Pancreas

AUTHOR(S)
Shin, Sang H.; Han, Duck J.; Park, Kwan T.; Kim, Young H.; Park, Jae B.; Kim, Song C.
PUB. DATE
April 2010
SOURCE
World Journal of Surgery;Apr2010, Vol. 34 Issue 4, p776
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The objective of the present study was to identify reliable preoperative factors predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm (IPMN) of the pancreas and the effectiveness of a diagnostic scoring system based on these factors. Between August 1994 and December 2007, 204 patients underwent pancreatic resection for IPMN at a single institute. Medical records were reviewed retrospectively, and a new diagnostic scoring system for predicting malignant IPMN preoperatively was designed. Univariate analysis revealed nine significant predictors of both malignant and invasive IPMN: age ≥60 years, history of pancreatitis, presence of mural nodule(s), diameter of main pancreatic duct (MPD) >6 mm, main duct or mixed type, total bilirubin >1.2 mg/dl, CA-19-9 >37 U/ml, tumor location in the pancreatic head, and tumor size >30 mm. Multivariate analysis showed that age, pancreatitis, mural nodule(s), and MPD diameter were independent predictors of invasive IPMN, and that all these parameters, plus elevated carbohydrate antigen-19-9 (CA-19-9), were independent predictors of malignant IPMN. A scoring system based on these five factors, each assigned 1 point, and with a cut-off of 3 points, could predict malignant IPMN with a sensitivity of 50.7% and a specificity of 90.1%. The 5-year survival rates of patients with benign and malignant IPMN were 95.0% and 64.0%, respectively. Our scoring system using five independent factors (age ≥60 years, history of pancreatitis, presence of mural nodule(s), elevated level of CA-19-9, and MPD diameter >6 mm) may be helpful for predicting malignancy and postoperative survival.
ACCESSION #
48409554

 

Related Articles

  • Consensus guidelines in the management of branch duct intraductal papillary mucinous neoplasm: a cost-effectiveness analysis. Huang, Edward S.; Gazelle, G. Scott; Hur, Chin // Digestive Diseases & Sciences;Mar2010, Vol. 55 Issue 3, p852 

    Background and Aims: Based on consensus guidelines, surgical resection of branch duct intraductal papillary mucinous neoplasm (BD-IPMN) is indicated in patients with symptoms of cyst size >or=30 mm, intramural nodules, or dilated main pancreatic duct greater than 6 mm. The aim of...

  • Cytological diagnosis of a rare case of solid pseudopapillary neoplasm of the pancreas. PAILOOR, KIRANA; KINI, HEMA; RAU, AARTHI R.; KUMAR, YOGESH // Journal of Cytology;Jan-Mar2010, Vol. 27 Issue 1, p32 

    A 23-year-old woman presented to our hospital with nonspecific pain in the abdomen. She underwent radiological investigations, which revealed a solid and cystic mass in the tail end of the pancreas. The mass was diagnosed to be solid pseudopapillary neoplasm of the pancreas on intraoperative...

  • Central Pancreatectomy with Pancreaticogastrostomy for the Treatment of a Solid-pseudopapillary Neoplasm. Dowden, Jacob E; Kimchi, Eric T; Camp, E Ramsay; Morgan, Katherine A; Adams, David B; Staveley-O'Carroll, Kevin F // American Surgeon;Nov2015, Vol. 81 Issue 11, pE383 

    No abstract available.

  • Factors Influencing the Outcome of Patients with Incidental Papillary Thyroid Microcarcinoma. Mantinan, Beatriz; Rego-Iraeta, Antonia; Larrañaga, Alejandra; Fluiters, Enrique; Sánchez-Sobrino, Paula; Garcia-Mayor, Ricardo V. // Journal of Thyroid Research;2012, p1 

    Objective: To analyze some factors that could influence the outcome of patients with PTMC. Material and Methods. This is a longitudinal observational study. All patients diagnosed and treated for papillary thyroid microcarcinoma at the University Hospital of Vigo, between January 1994 and...

  • Simultaneous Extensive Intraductal Papillary Neoplasm of the Bile Duct and Pancreas: A Very Rare Entity. Luvira, Vor; Pugkhem, Ake; Tipwaratorn, Theerawee; Chamgramol, Yaovalux; Pairojkul, Chawalit; Bhudhisawasdi, Vajarabhongsa // Case Reports in Surgery;1/26/2016, p1 

    Intraductal papillary neoplasm of the bile duct (IPNB) is a specific type of bile duct tumor. It has been proposed that it could be the biliary counterpart of the intraductal papillary neoplasm of the pancreas (IPMN-P). This hypothesis is supported by the presence of simultaneous intraductal...

  • Biological Behavior of Papillary Carcinoma of the Thyroid Including Squamous Cell Carcinoma Components and Prognosis of Patients Who Underwent Locally Curative Surgery. Ito, Yasuhiro; Hirokawa, Mitsuyoshi; Higashiyama, Takuya; Kihara, Minoru; Tomoda, Chisato; Takamura, Yuuki; Kobayashi, Kaoru; Miya, Akihiro; Miyauchi, Akira // Journal of Thyroid Research;2012, p1 

    Thyroid carcinoma showing squamous differentiation throughout the entire lesion is diagnosed as squamous cell carcinoma of the thyroid (SCCT) in the WHO classification. This entity is a rare disease and shows a dire prognosis; however, squamous differentiation ismore frequently detected in only...

  • Anaplastic carcinoma of the pancreas arising in an intraductal papillary mucinous neoplasm: A case report. KENSUKE FUJII; TOSHIKATSU NITTA; HIROSHI KAWASAKI; JUN KATAOKA; TOMO TOMINAGA; YOSHIHIRO INOUE; EIJI KADOTA; TAKASHI ISHIBASHI; KAZUHISA UCHIYAMA // Molecular & Clinical Oncology;Jan2016, Vol. 4 Issue 1, p39 

    We herein report a case of anaplastic carcinoma of the pancreas arising in an intraductal papillary mucinous neoplasm (IPMN). A 68-year-old Japanese woman was admitted to our hospital complaining of fatigue. Computed tomography revealed an irregular mass in the pancreatic head, which displayed...

  • The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma. von Figura, Guido; Fukuda, Akihisa; Roy, Nilotpal; Liku, Muluye E.; Morris IV, John P.; Kim, Grace E.; Russ, Holger A.; Firpo, Matthew A.; Mulvihill, Sean J.; Dawson, David W.; Ferrer, Jorge; Mueller, William F.; Busch, Anke; Hertel, Klemens J.; Hebrok, Matthias // Nature Cell Biology;Mar2014, Vol. 16 Issue 3, p255 

    Pancreatic ductal adenocarcinoma (PDA) develops through distinct precursor lesions, including pancreatic intraepithelial neoplasia (PanIN) and intraductal papillary mucinous neoplasia (IPMN). However, genetic features resulting in IPMN-associated PDA (IPMN-PDA) versus PanIN-associated PDA...

  • Papillocystic Variant of Acinar Cell Pancreatic Carcinoma. Radhi, Jasim; Tse, France; Marcaccio, Michael // Journal of Oncology;2010, p1 

    Acinar cell pancreatic carcinoma is a rare solid malignant neoplasm. Recent review of the literature showed occasional cases with papillary or papillocystic growth patterns, ranging from 2 to 5 cm in diameter. We report a large 10 cm pancreatic tumor with papillocystic pathology features...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics